Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol acetate in persistent asthma
2012-000520-18Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of indacaterol in asthma and persistent asthma (3 arms), sponsored by Novartis. Primary endpoint: Trough Forced Expiratory Volume in one second (FEV1). Started Jul 2012; status: completed.
02
Drugs
indacaterol
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2012-000520-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000520-18.